Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10146)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
HPCAL1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Responsed Disease | Acute pancreatitis | ICD-11: DC31 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Autophagy | hsa04140 | ||||
Cell Process | Cell ferroptosis | ||||
Cell autophagy | |||||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 | |
Calu-1 cells | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | ||
PANC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | ||
5637 cells | Bladder carcinoma | Homo sapiens | CVCL_0126 | ||
SK-OV-3 cells | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 | ||
PC-3 cells | Prostate carcinoma | Homo sapiens | CVCL_0035 | ||
In Vivo Model |
Pancreatic-specific gpx4 knockout mice were produced and identified in our laboratory by crossing floxed Gpx4 (a gift from Dr. Qitao Ran, UT Health San Antonio) and Pdx1-Cre (the Jackson Laboratory, 014647) transgenic mice (C57BL/6J background). For cerulein-induced acute pancreatitis, female mice (8-10 weeks) received seven hourly i.p. injections of 50 ug/kg cerulein in sterile saline. We repeatedly administered iHPCAL1 by i.p. at a dose of 10 mg/kg to mice at 3 and 12 h after the first cerulein injection, while controls were treated by administration with vehicle. The parameters of acute pancreatitis were assessed 12 h after the last cerulein treatment.
Click to Show/Hide
|
||||
Response regulation | HPCAL1 as a specific autophagy receptor provides the first mechanistic understanding of how CDH2 is selectively delivered to phagophores, leading to CDH2 degradation for the induction of ferroptosis. The genetic or pharmacological inhibition of HPCAL1 prevented ferroptosis-induced tumor suppression and pancreatitis in suitable mouse models. | ||||
Acute pancreatitis [ICD-11: DC31]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Hippocalcin-like protein 1 (HPCAL1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Autophagy | hsa04140 | ||||
Cell Process | Cell ferroptosis | ||||
Cell autophagy | |||||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 | |
Calu-1 cells | Lung squamous cell carcinoma | Homo sapiens | CVCL_0608 | ||
PANC-1 cells | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | ||
5637 cells | Bladder carcinoma | Homo sapiens | CVCL_0126 | ||
SK-OV-3 cells | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 | ||
PC-3 cells | Prostate carcinoma | Homo sapiens | CVCL_0035 | ||
In Vivo Model |
Pancreatic-specific gpx4 knockout mice were produced and identified in our laboratory by crossing floxed Gpx4 (a gift from Dr. Qitao Ran, UT Health San Antonio) and Pdx1-Cre (the Jackson Laboratory, 014647) transgenic mice (C57BL/6J background). For cerulein-induced acute pancreatitis, female mice (8-10 weeks) received seven hourly i.p. injections of 50 ug/kg cerulein in sterile saline. We repeatedly administered iHPCAL1 by i.p. at a dose of 10 mg/kg to mice at 3 and 12 h after the first cerulein injection, while controls were treated by administration with vehicle. The parameters of acute pancreatitis were assessed 12 h after the last cerulein treatment.
Click to Show/Hide
|
||||
Response regulation | HPCAL1 as a specific autophagy receptor provides the first mechanistic understanding of how CDH2 is selectively delivered to phagophores, leading to CDH2 degradation for the induction of ferroptosis. The genetic or pharmacological inhibition of HPCAL1 prevented ferroptosis-induced tumor suppression and pancreatitis in suitable mouse models. | ||||